193 related articles for article (PubMed ID: 19494202)
1. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.
Yanni SE; Barnett JM; Clark ML; Penn JS
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5479-86. PubMed ID: 19494202
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E
Xie T; Zhang Z; Cui Y; Shu Y; Liu Y; Zou J; Wang M; Wang Y; Yang Q; Pan X; Cai J; Sun X; Yao Y; Wang X
Exp Eye Res; 2021 Apr; 205():108507. PubMed ID: 33609510
[TBL] [Abstract][Full Text] [Related]
3. Role of cytosolic phospholipase A(2) in retinal neovascularization.
Barnett JM; McCollum GW; Penn JS
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1136-42. PubMed ID: 19661235
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
5. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
6. The effects of nepafenac and amfenac on retinal angiogenesis.
Yanni SE; Clark ML; Yang R; Bingaman DP; Penn JS
Brain Res Bull; 2010 Feb; 81(2-3):310-9. PubMed ID: 19897019
[TBL] [Abstract][Full Text] [Related]
7. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
8. The role of cytochrome P450 epoxygenases in retinal angiogenesis.
Capozzi ME; McCollum GW; Penn JS
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4253-60. PubMed ID: 24917142
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a.
Zaniolo K; Sapieha P; Shao Z; Stahl A; Zhu T; Tremblay S; Picard E; Madaan A; Blais M; Lachapelle P; Mancini J; Hardy P; Smith LE; Ong H; Chemtob S
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5376-86. PubMed ID: 21642627
[TBL] [Abstract][Full Text] [Related]
11. The role of the NFAT signaling pathway in retinal neovascularization.
Bretz CA; Savage S; Capozzi M; Penn JS
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):7020-7. PubMed ID: 24052639
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells.
Yanni SE; McCollum GW; Penn JS
Exp Eye Res; 2010 Jul; 91(1):34-41. PubMed ID: 20398651
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
14. Knockout of αA-crystallin inhibits ocular neovascularization.
Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
[TBL] [Abstract][Full Text] [Related]
16. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685
[TBL] [Abstract][Full Text] [Related]
17. CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10.
Bucher F; Aguilar E; Marra KV; Rapp J; Arnold J; Diaz-Aguilar S; Lange C; Agostini H; Schlunck G; Stahl A; Friedlander M
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):20. PubMed ID: 32780864
[TBL] [Abstract][Full Text] [Related]
18. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
[TBL] [Abstract][Full Text] [Related]
19. Recombinant alpha2(IV)NC1 domain of type IV collagen is an effective regulator of retinal capillary endothelial cell proliferation and inhibits pre-retinal neovascularisation.
Coleman G; Gardiner TA; Boutaud A; Stitt AW
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):581-7. PubMed ID: 16915401
[TBL] [Abstract][Full Text] [Related]
20. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
